APA

Ohkawa T., Morimoto S., Okuyama A., Yoshioka T., Kishimoto T., Kurita T., Ikoma F., Itatani H., Koide T. & Ogawa N. (19971119). [Clinical phase III study of cimetropium bromide (DA3177) on the pain with upper urinary calculus: a double-blind study in comparison with scopolamine butylbromide. DA3177 Study Group]. : Hinyokika kiyo. Acta urologica Japonica.

Chicago

Ohkawa T, Morimoto S, Okuyama A, Yoshioka T, Kishimoto T, Kurita T, Ikoma F, Itatani H, Koide T and Ogawa N. 19971119. [Clinical phase III study of cimetropium bromide (DA3177) on the pain with upper urinary calculus: a double-blind study in comparison with scopolamine butylbromide. DA3177 Study Group]. : Hinyokika kiyo. Acta urologica Japonica.

Harvard

Ohkawa T., Morimoto S., Okuyama A., Yoshioka T., Kishimoto T., Kurita T., Ikoma F., Itatani H., Koide T. and Ogawa N. (19971119). [Clinical phase III study of cimetropium bromide (DA3177) on the pain with upper urinary calculus: a double-blind study in comparison with scopolamine butylbromide. DA3177 Study Group]. : Hinyokika kiyo. Acta urologica Japonica.

MLA

Ohkawa T, Morimoto S, Okuyama A, Yoshioka T, Kishimoto T, Kurita T, Ikoma F, Itatani H, Koide T and Ogawa N. [Clinical phase III study of cimetropium bromide (DA3177) on the pain with upper urinary calculus: a double-blind study in comparison with scopolamine butylbromide. DA3177 Study Group]. : Hinyokika kiyo. Acta urologica Japonica. 19971119.